Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_4

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 4Post-market surveillance

2(66.7%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(1)

Other(1)

Detailed Status

Completed1

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 42 (66.7%)

N/A1 (33.3%)

Trials by Status

completed133%

unknown133%

withdrawn133%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_4

Multi-Center Study To Examine The Use Of Flex HD® And Strattice In The Repair Of Large Abdominal Wall Hernias

NCT01987700

unknownnot_applicable

Dermacell ADM Without Basement Membrane

NCT03667560

withdrawnphase_4

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

NCT02372305

Clinical Trials (3)

Showing 3 of 3 trials

NCT01987700Phase 4

Multi-Center Study To Examine The Use Of Flex HD® And Strattice In The Repair Of Large Abdominal Wall Hernias

Completed

NCT03667560Not Applicable

Dermacell ADM Without Basement Membrane

Unknown

NCT02372305Phase 4

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3